Antibody Drug Conjugate Drug Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Coverage: Antibody Drug Conjugate Drug Market covers analysis By Product (Adcertis, Kadcyla); Technology (ImmunoGen technology, Seattle Genetics technology, Immunomedics technology); End User (Hospitals, Specialized Cancer Centers, Academic Research Institutes, Biotechnology Companies, Biopharmaceutical Companies, Others) , and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Code : TIPRE00016840
  • Category : Pharmaceuticals
  • No. of Pages : 150
Buy Now

Antibody Drug Conjugate Drug Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Buy Now

MARKET INTRODUCTION

Antibody Drug Conjugate Drug is the class of highly potent biopharmaceutical anticancer agents. Antibody drug conjugates have monoclonal antibodies which targets on the specific target site of tumor to destroy cancer cells. Antibody drug conjugates having very potent anti-cancer agents which are linked each other's via a chemical linkage. Antibody drug conjugates have a wide application in oncology and hematology.

MARKET DYNAMICS

The key market drivers for Antibody Drug Conjugate Drug Market Includes, rising prevalence of cancer patients globally especially several grades of lymphomas and solid tumor cancers. Moreover, high R&D investments by biopharmaceutical industries is also expected to boost market growth during the forecast period. Whereas, high cost of the therapy and possible cytotoxity and other side effects due to antibody drug conjugates may have negative impact on market growth during the forecast period.

MARKET SCOPE

The "Antibody Drug Conjugate Drug Market" is a specialized and in-depth study of the Pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Antibody Drug Conjugate Drug market with detailed market segmentation by product, technology and end user. The Antibody Drug Conjugate Drug Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Antibody Drug Conjugate Drug Market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Antibody Drug Conjugate Drug Market is segmented on the basis of product, technology and end user. On the basis of product the market is segmented as, Adcertis, Kadcyla. On the basis of technology the market can be segmented as, immunogen technology, seattle genetics technology and immunomedics technology, And on the basis of end user the market is segmented as, hospitals, cancer centers, academic and research institutes, biopharmaceutical companies and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Antibody Drug Conjugate Drug Market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Antibody Drug Conjugate Drug Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Antibody Drug Conjugate Drug Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Antibody Drug Conjugate Drug Market in these regions.

Antibody Drug Conjugate Drug Market Report Analysis

Antibody Drug Conjugate Drug Market

  • CAGR (2023 - 2031)
    XX%
  • Market Size 2023
    US$ XX Million
  • Market Size 2031
    US$ XX Million

Report Coverage

  • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Key future trends
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Industry landscape and competition analysis & recent developments
  • Detailed company profiles
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

  • Genentech USA, Inc
  • Seattle Genetics
  • F. Hoffmann-La Roche Ltd
  • Takeda Pharmaceuticals
  • Pfizer Inc
  • AbbVie Inc
  • Immunomedics
  • ImmunoGen Inc
  • Lonza

Regional Overview

  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Market Segmentation

By Product
  • Adcertis
  • Kadcyla
By Technology
  • ImmunoGen technology
  • Seattle Genetics technology
  • Immunomedics technology
By End User
  • Hospitals
  • Specialized Cancer Centers
  • Academic Research Institutes
  • Biotechnology Companies
  • Biopharmaceutical Companies
  • Others
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
MARKET PLAYERS


The report covers key developments in the Antibody Drug Conjugate Drug Markets organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Antibody Drug Conjugate Drug Market are anticipated to have lucrative growth opportunities in the future with the rising demand for, Antibody Drug Conjugate Drug market in the global market. Below mentioned is the list of few companies engaged in the Antibody Drug Conjugate Drug Market.

The report also includes the profiles of key players in Antibody Drug Conjugate Drug Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.

  •   Genentech USA,Inc
  •   Seattle Genetics
  •   F. Hoffmann -La Roche Ltd
  •   Takeda Pharmaceuticals
  •   Pfizer, Inc
  •   AbbVie Inc
  •   Immunomedics
  •   ImmunoGen, Inc
  •   Lonza
  •   Creative Biolabs

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.

Antibody Drug Conjugate Drug Market Report Scope

Report Attribute Details
Market size in 2023 US$ XX Million
Market Size by 2031 US$ XX Million
Global CAGR (2023 - 2031) XX%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Product
  • Adcertis
  • Kadcyla
By Technology
  • ImmunoGen technology
  • Seattle Genetics technology
  • Immunomedics technology
By End User
  • Hospitals
  • Specialized Cancer Centers
  • Academic Research Institutes
  • Biotechnology Companies
  • Biopharmaceutical Companies
  • Others
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Genentech USA, Inc
  • Seattle Genetics
  • F. Hoffmann-La Roche Ltd
  • Takeda Pharmaceuticals
  • Pfizer Inc
  • AbbVie Inc
  • Immunomedics
  • ImmunoGen Inc
  • Lonza
    • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
    Report Coverage
    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered
    Segment Covered

    This text is related
    to segments covered.

    Regional Scope
    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope
    Country Scope

    This text is related
    to country scope.

    The List of Companies

    1. Genentech USA, Inc
    2. Seattle Genetics
    3. F. Hoffmann-La Roche Ltd
    4. Takeda Pharmaceuticals
    5. Pfizer Inc
    6. AbbVie Inc
    7. Immunomedics
    8. ImmunoGen Inc
    9. Lonza
    10. Creative Biolabs

    Trends and growth analysis reports related to Pharmaceuticals : READ MORE..